53 related articles for article (PubMed ID: 21272286)
1. Gene expressing profiling of iris melanomas.
Harbour JW; Wilson D; Finger PT; Worley LA; Onken MD
Ophthalmology; 2013 Jan; 120(1):213, 213.e1-3. PubMed ID: 23283188
[No Abstract] [Full Text] [Related]
2. Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.
Bidard FC; Madic J; Mariani P; Piperno-Neumann S; Rampanou A; Servois V; Cassoux N; Desjardins L; Milder M; Vaucher I; Pierga JY; Lebofsky R; Stern MH; Lantz O
Int J Cancer; 2014 Mar; 134(5):1207-13. PubMed ID: 23934701
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity and molecular landscape of melanoma: implications for targeted therapy.
Beigi YZ; Lanjanian H; Fayazi R; Salimi M; Hoseyni BHM; Noroozizadeh MH; Masoudi-Nejad A
Mol Biomed; 2024 May; 5(1):17. PubMed ID: 38724687
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma.
de Bruyn DP; van Poppelen NM; Brands T; van den Boom SC; Eikenboom E; Wagner A; van Veghel-Plandsoen MM; Geeven G; Beverloo B; van Rij CM; Verdijk RM; Naus NC; Bagger MM; Kiilgaard JF; de Klein A; Brosens E; Kiliç E
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):11. PubMed ID: 38319670
[TBL] [Abstract][Full Text] [Related]
5. Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience.
Mazzini C; Vicini G; Di Leo L; Massi D; Rizzo S; Giansanti F
Life (Basel); 2023 Mar; 13(4):. PubMed ID: 37109431
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture.
Beasley AB; Isaacs TW; Vermeulen T; Freeman J; DeSousa JL; Bhikoo R; Hennessy D; Reid A; Chen FK; Bentel J; McKay D; Conway RM; Pereira MR; Mirzai B; Calapre L; Erber WN; Ziman MR; Gray ES
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885099
[TBL] [Abstract][Full Text] [Related]
7. Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma.
Anand K; Roszik J; Gombos D; Upshaw J; Sarli V; Meas S; Lucci A; Hall C; Patel S
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31226786
[TBL] [Abstract][Full Text] [Related]
8. The biology of uveal melanoma.
Amaro A; Gangemi R; Piaggio F; Angelini G; Barisione G; Ferrini S; Pfeffer U
Cancer Metastasis Rev; 2017 Mar; 36(1):109-140. PubMed ID: 28229253
[TBL] [Abstract][Full Text] [Related]
9. Uveal melanoma dormancy: an acceptable clinical endpoint?
Blanco PL; Lim LA; Miyamoto C; Burnier MN
Melanoma Res; 2012 Oct; 22(5):334-40. PubMed ID: 22895346
[TBL] [Abstract][Full Text] [Related]
10. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
Shildkrot Y; Wilson MW
Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
[TBL] [Abstract][Full Text] [Related]
11. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.
Suesskind D; Ulmer A; Schiebel U; Fierlbeck G; Spitzer B; Spitzer MS; Bartz-Schmidt KU; Grisanti S
Acta Ophthalmol; 2011 Feb; 89(1):17-24. PubMed ID: 21272286
[TBL] [Abstract][Full Text] [Related]
12. Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.
Ulmer A; Beutel J; Süsskind D; Hilgers RD; Ziemssen F; Lüke M; Röcken M; Rohrbach M; Fierlbeck G; Bartz-Schmidt KU; Grisanti S
Clin Cancer Res; 2008 Jul; 14(14):4469-74. PubMed ID: 18628461
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
14. Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey.
Ly LV; Odish OF; Wolff-Rouendaal Dd; Missotten GS; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):658-65. PubMed ID: 19797220
[TBL] [Abstract][Full Text] [Related]
15. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
